Presentation of sebaceous carcinoma and dermatofibrosarcoma protuberans subsequent to intralesional interferon alfa-2b for the treatment of in situ squamous cell carcinoma.
Wagner
R F
RF
Sanchez
R L
RL
D000230:Adenocarcinoma / Q000139:chemically induced*; D000368:Aged; D002294:Carcinoma, Squamous Cell / Q000628:therapy; D005354:Fibrosarcoma / Q000139:chemically induced*; D006801:Humans; D015552:Injections, Intralesional; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins; D012535:Scalp; D012626:Sebaceous Gland Neoplasms / Q000139:chemically induced*; D012878:Skin Neoplasms / Q000139:chemically induced*
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins